Several markers of inflammation and endothelial dysfunction are associated with the elevated risk of cardiovascular disease (CVD) seen in patients with type 2 diabetes, independently of conventional ...

Discover comprehensive details about Repaglinide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Repaglinide belongs to a group of diabetes drugs called meglitinides. It comes as a tablet you take by mouth. Keep reading for details on repaglinide and cost, and how to save money on prescriptions.

May 16, 2003 — In two separate randomized trials presented at the American Academy of Clinical Endocrinology annual meeting, repaglinide was more effective than nateglinide in type 2 diabetes.

Repaglinide is a meglitinide antidiabetic, prescribed for type 2 (non-insulin-dependent) diabetes.

Dr. Tsimikas answers the question: 'What Is Nateglinide And Repaglinide?' — -- Question:What is nateglinide and repaglinide, and when are they used? Answer:Nateglinide and repaglinide are two ...

Drug–drug interactions between antidiabetic agents and other pharmacological compounds may be two-sided. For those antidiabetic drugs that are metabolized via the CYP450 isoenzymes, concomitant ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Lean older adults with type 2 diabetes experienced lower ...

Type 2 diabetes care often targets both fasting and post-meal glucose. Repaglinide is a short-acting option for postprandial control. Its safety profile is tightly linked to meal timing, ...

Today, Novo Nordisk announced that Judge Avern Cohn of the US District Court for the Eastern District of Michigan issued an adverse ruling in a patent litigation case regarding Novo Nordisk's US ...